accounta potential acquisition with Westport, Connecticut-based Advanced BioHealing since 2008, said Mike Cola, president of Shire���s specialty pharmaceuticals business. The biotechnology company now will become the focal point of Shire���s new regenerative...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Shire Hits ���Sweet Spot��� With $750 Million U.S. Acquisition
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account